Hyperphenylalaninaemia

Inborn Metabolic Diseases: Diagnosis and Treatment

Volumn , Issue , 2006, Pages 221-232

  Walter, John H ^a   Lee, Philip J ^b   Burgard, Peter ^c  

^a ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84895318434     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-28785-8_17     Document Type: Chapter

References (49)

1. Folling I (1994) The discovery of phenylketonuria. Acta Paediatr Suppl 407:4-10
2. The Maternal Phenylketonuria Collaborative Study: a status report (1994) Nutr Rev 52:390-393
3. Pietz J, Benninger C, Schmidt H et al (1988) Long-term development of intelligence (IQ) and EEG in 34 children with phenylketonuria treated early. Eur J Pediatr 147:361-367
4. Kreis R (2000) Comments on in vivo proton magnetic resonance spectroscopy in phenylketonuria. Eur J Pediatr 159 [Suppl 2]: S126-S128
5. Guldberg P, Rey F, Zschocke J et al (1998) A European Multicenter Study of Phenylalanine Hydroxylase Deficiency: Classification of 105 mutations and a general system for genotype-based pre diction of metabolic phenotype. Am J Hum Genet 63:71-79
6. Lichter Konecki U, Rupp A, Konecki DS et al (1994) Relation between phenylalanine hydroxylase genotypes and phenotypic parameters of diagnosis and treatment of hyperphenylalani naemic disorders. German Collaborative Study of PKU. J Inherit Metab Dis 17:362-365
7. Bartholome K, Lutz P, Bickel H (1975) Determination of phenylalanine hydroxylase activity in patients with phenylketonuria and hyperphenylalaninemia. Pediatr Res 9:899-903
8. Trefz FK, Bartholome K, Bickel H et al (1981) In vivo residual activities of the phenylalanine hydroxylating system in phenylketonuria and variants. J Inherit Metab Dis 4:101-102
9. Scriver CR, Kaufman S (2001) Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 1667-1724
10. Anonymous (1993) Recommendations on the dietary management of phenylketonuria. Report of Medical Research Council Working Party on Phenylketonuria. Arch Dis Child 68:426-427
11. Burgard P, Bremer HJ, Buhrdel P et al (1999) Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997. Eur J Pediatr 158:46-54
12. National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16-18, 2000 (2001) Pediatrics 108:972-982
13. Ding Z, Harding CO, Thony B (2004) State-of-the-art 2003 on PKU gene therapy. Mol Genet Metab 81:3-8
14. Sarkissian CN, Shao Z, Blain F et al (1999) A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase. Proc Natl Acad Sci U S A 96:2339-2344
15. Liu J, Jia X, Zhang J et al (2002) Study on a novel strategy to treatment of phenylketonuria. Artif Cells Blood Substit Immobil Biotechnol 30:243-257
16. Koch R, Moseley KD, Yano S et al (2003) Large neutral amino acid therapy and phenylketonuria: a promising approach to treatment. Mol Genet Metab 79:110-113
17. Matalon R, Surendran S, Matalon KM et al (2003) Future role of large neutral amino acids in transport of phenylalanine into the brain. Pediatrics 112(6 Pt 2):1570-1574
18. Muntau AC, Roschinger W, Habich M et al (2002) Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. N Engl J Med 347:2122-2132
19. Blau N, Erlandsen H (2004) The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Mol Genet Metab 82:101-111
20. Burgard P, Schmidt E, Rupp A et al (1996) Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria. Eur J Pediatr 155 [Suppl 1]: S33-S38
21. Walter JH, White FJ, Hall SK et al (2002) How practical are recommendations for dietary control in phenylketonuria? Lancet 360:55-57
22. Camfield CS, Joseph M, Hurley T et al (2004) Optimal management of phenylketonuria: a centralized expert team is more successful than a decentralized model of care. J Pediatr 145:53-57
23. Smith I, Beasley MG, Ades AE (1990) Intelligence and quality of dietary treatment in phenylketonuria. Arch Dis Child 65:472-478
24. Smith I, Beasley MG, Ades AE (1991) Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria. Arch Dis Child 66:311-316
25. Burgard P, Link R, Schweitzer-Krantz S (2000) Phenylketonuria: evidence-based clinical practice. Summary of the roundtable discussion. Eur J Pediatr 159 [Suppl 2]: S163-S168
26. Lundstedt G, Johansson A, Melin L et al (2001) Adjustment and intelligence among children with phenylketonuria in Sweden. Acta Paediatr 90:1147-1152
27. Welsh M, Pennington B (2000) Phenylketonuria. In: Yeates KO, Ris MD, Taylor HG (eds) Pediatric neuropsychology. Guildford Press, New York, pp 275-299
28. Cleary MA, Walter JH, Wraith JE et al (1995) Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change. J Pediatr 127:251-255
29. Feldmann R, Denecke J, Pietsch M et al (2002) Phenylketonuria: no specific frontal lobe-dependent neuropsychological deficits of early-treated patients in comparison with diabetics. Pediatr Res 51:761-765
30. Thompson AJ, Smith I, Brenton D et al (1990) Neurological deterioration in young adults with phenylketonuria. Lancet 336:602-605
31. Lee P, Smith I, Piesowicz A et al (1999) Spastic paraparesis after anaesthesia. Lancet 353:554
32. Robinson M, White FJ, Cleary MA et al (2000) Increased risk of vitamin B12 deficiency in patients with phenylketonuria on an unrestricted or relaxed diet. J Pediatr 136:545-547
33. Discussion of Armstrong MD (1957) The relation of biochemical abnormality to the development of mental defect in phenylketonuria. Columbus Ohio: Ross Laboratories
34. Lenke RR, Levy HL (1980) Maternal phenylketonuria and hyperphenylalaninaemia. An international survey of the outcome of of untreated and treated pregnancies. N Engl J Med 303:1202-1208
35. Koch R, Hanley W, Levy H et al (2003) The Maternal Phenylketonuria International Study: 1984-2002. Pediatrics 112(6 Pt 2):1523-1529
36. Lee PJ, Ridout D, Walter JH et al (2005) Maternal phenylketonuria: report from the United Kingdom Registry 1978-97. Arch Dis Child 90:143-146
37. Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. Medical Research Council Working Party on Phenylketonuria (1993) BMJ 306:115-119
38. Soltesz G, Harris D, Mackenzie IZ et al (1985) The metabolic and endocrine milieu of the human fetus and mother at 18-21 weeks of gestation. I. Plasma amino acid concentrations. Pediatr Res 19:91-93
39. Lee PJ, Lilburn M, Baudin J (2003) Maternal phenylketonuria: experiences from the United Kingdom. Pediatrics 112(6 Pt 2):1553-1556
40. American Academy of Pediatrics: Maternal phenylketonuria (2001) Pediatrics 107:427-428
41. Koch R, Hanley W, Levy H et al (2000) Maternal phenylketonuria: an international study. Mol Genet Metab 71:233-239
42. Levy HL, Waisbren SE, Guttler F et al (2003) Pregnancy experiences in the woman with mild hyperphenylalaninemia. Pediatrics 112(6 Pt 2):1548-1552
43. Ponzone A, Guardamagna O, Spada M et al (1993) Differential diagnosis of hyperphenylalaninaemia by a combined phenylalaninetetrahydrobiopterin loading test. Eur J Pediatr 152:655-661
44. Hyland K, Surtees RA, Heales SJ et al (1993) Cerebrospinal fluid concentrations of pterins and metabolites of serotonin and dopamine in a pediatric reference population. Pediatr Res 34:10-14
45. Smith I, Hyland K, Kendall B (1985) Clinical role of pteridine therapy in tetrahydrobiopterin deficiency. J Inherit Metab Dis 8 [Suppl 1]: 39-45
46. Hyland K (1993) Abnormalities of biogenic amine metabolism. J Inherit Metab Dis 16:676-690
47. Spada M, Ferraris S, Ferrero GB et al (1996) Monitoring treatment in tetrahydrobiopterin deficiency by serum prolactin. J Inherit Metab Dis 19:231-233
48. Schuler A, Kalmanchey R, Barsi P et al (2000) Deprenyl in the treatment of patients with tetrahydrobiopterin deficiencies. J Inherit Metab Dis 23:329-332
49. Ponzone A, Spada M, Ferraris S et al (2004) Dihydropteridine reductase deficiency in man: from biology to treatment. Med Res Rev 24:127-150